Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI diet coach aims to fix Cancer's taste troubles

NCT ID NCT07649681

First seen Jun 23, 2026 · Last updated Jun 23, 2026

Summary

This study tests whether an AI-based website that gives personalized food tips and recipes can help cancer patients who experience taste changes during therapy. About 198 adults with multiple myeloma, melanoma, GI, or urogenital cancers will be randomly assigned to receive either the AI recommendations or a standard advice flyer. The goal is to see if the personalized approach improves nutrition and reduces malnutrition risk over 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Klinikum der Technischen Universität München (TUM Klinikum)

    München, Bavaria, 81675, Germany

  • LMU Klinikum Krebszentrum - CCC MünchenLMU - Comprehensive Cancer Center

    München, Bavaria, 81377, Germany

  • Universitätsklinikum Augsburg

    Augsburg, Bavaria, 86156, Germany

  • Universitätsklinikum Erlangen

    Erlangen, Bavaria, 91054, Germany

  • Universitätsklinikum Regensburg

    Regensburg, Bavaria, 93053, Germany

  • Universitätsklinikum Würzburg

    Würzburg, Bavaria, 97080, Germany

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AI-based web platform providing personalized dietary and recipe recommendations

What this could lead to

If successful, this could offer a practical, personalized way to help cancer patients manage taste changes and avoid malnutrition during treatment.

What could go wrong

This is a phase 2 study with no prior efficacy data, and the intervention relies on patient engagement with an online portal, which may not suit everyone.

Conditions

The condition(s) this trial relates to.

Gastrointestinal Neoplasms Melanoma Multiple Myeloma Taste Disorders Urogenital Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.